Highlights From the San Antonio Breast Cancer Symposium 2020
My top three takeaways from the 2020 San Antonio Breast Cancer Symposium.
Tag: Hormone Receptor-Positive Breast Cancer
Targeted Treatments for Hormone Receptor-Positive Breast Cancer
There were some noteworthy developments this year in targeted therapies for hormone receptor-positive breast cancer.
Breast Cancer Treatment: The TAILORx Clinical Trial
Findings from the TAILORx clinical trial will help personalize treatment decisions for many patients with early stage breast cancer.
A Role for Progesterone in Breast Cancer Treatment?
New clinical trials will test whether the addition of progesterone could improve treatment for hormone receptor-positive breast cancer.
5 Cancer Research Stories Worth Following – Summer 2016
Cancer research stories worth following this summer include reports from ASCO on a web app that improves survival for lung cancer patients and a “biosimilar” treatment for the breast cancer drug Herceptin.
San Antonio Breast Cancer Symposium 2015: “These Data Belong to Our Patients”
Research findings presented at the 2015 San Antonio Breast Cancer Symposium may preview an era in which breast cancer treatments will be tailored to each patient.
Hormone Receptor-Positive Breast Cancer: A Look At New Research Findings
New discoveries about the role of the hormone progesterone in breast cancer could potentially lead to improved treatment options for many breast cancer patients.
After 20 Years 